{"id":"W1522387304","doi":"10.1111/j.2040-1124.2011.00122.x","title":"Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial","year":2011,"lang":"en","type":"article","venue":"Journal of Diabetes Investigation","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer Japan; Soochow University; Astellas Pharma; Pfizer; Daiichi-Sankyo; Novo Nordisk; Eisai; Sanofi; Eli Lilly and Company","keywords":"Pregabalin; Medicine; Placebo; Neuropathic pain; Visual analogue scale; McGill Pain Questionnaire; Peripheral edema; Adverse effect; Anesthesia; Peripheral neuropathy; Somnolence; Analgesic; Randomized controlled trial; Diabetes mellitus; Clinical trial; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003878127,0.00187464,0.005142755,0.0006451793,0.0009487243,0.001177743,0.001022839,0.002583683,0.006232617],"category_scores_gemma":[0.003047936,0.0007732014,0.002854777,0.0005746917,0.001221416,0.001273164,0.0005413677,0.002607408,0.001079802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007199651,"about_ca_system_score_gemma":0.001106019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005280894,"about_ca_topic_score_gemma":0.0008626402,"domain_scores_codex":[0.9977131,0.001054094,0.000313141,0.0004899552,0.0001712756,0.000258422],"domain_scores_gemma":[0.9970973,0.0006954934,0.0008558607,0.0003119084,0.0003309534,0.0007086702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9814166,0.006797677,0.0005488873,0.0004624808,0.0005637109,0.00002009667,0.00002882518,0.00009434895,0.001983829,0.00001336297,0.0001206868,0.007949488],"study_design_scores_gemma":[0.8790644,0.1163275,0.003241346,0.0000336213,0.000479099,0.00001949924,0.00001250128,0.000189265,0.0003963664,0.00002718759,0.0001937309,0.00001548601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862876,0.006058995,0.000735837,0.0003462652,0.0004809838,0.004279031,0.0006504585,0.0001184615,0.001042282],"genre_scores_gemma":[0.9853116,0.002337344,0.00151177,0.0006982714,0.0006906884,0.006948822,0.0007130684,0.00002033047,0.001768149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006232617,"threshold_uncertainty_score":0.02085018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03472515554063992,"score_gpt":0.2700028576374754,"score_spread":0.2352777020968355,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}